Physician profile
Mary E Mcclain
NPI 1992244495
$766.49
in general payments reported to CMS, 2019-2025
11 companies · $64.06 in 2025
The $64.06 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $85.84 · 2022: $313 · 2023: $240 · 2024: $64.02 · 2025: $64.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $367.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $198.10 | 2021-2023 | Wegovy |
| Boston Scientific Corporation | $174.61 | 2023-2025 | Solyx Sis System, Advantage System |
| Channel Medsystems, INC. | $129.02 | 2022 | |
| Abbvie INC. | $113.76 | 2021-2025 | |
| Exact Sciences Corporation | $33.73 | 2023 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $29.65 | 2024 | Aptima |
| Aspira Women'S Health INC | $28.93 | 2021 | |
| Mayne Pharma Commercial LLC | $17.57 | 2022 | |
| Urovant Sciences INC | $14.75 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.40 | 2022 | |
| Evofem Biosciences, INC. | $11.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Mcclain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.